NCT07809191

Brief Summary

Participants are being approached to participate in this study because they are undergoing surgery for a skin cancer known as squamous cell carcinoma in situ (SCCIS) on the scalp. Standard surgical techniques may remove deeper structures that contain hair follicles, which can result in permanent hair loss. This study evaluates whether a modified surgical technique, known as partial thickness excision, can preserve hair growth and improve cosmetic outcomes. Participation involves minimal risk beyond the standard risks of Mohs surgery. If patients choose to participate, their surgery will be performed using this technique, and photographs will be taken over time to evaluate hair regrowth and healing.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
22mo left

Started Sep 2026

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress5%
Sep 2026Jul 2028

First Submitted

Initial submission to the registry

August 4, 2026

Completed
28 days until next milestone

Study Start

First participant enrolled

September 1, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 9, 2026

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 17, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

July 17, 2028

Last Updated

September 9, 2026

Status Verified

July 1, 2026

Enrollment Period

11 months

First QC Date

August 4, 2026

Last Update Submit

September 2, 2026

Conditions

Keywords

mohs micrographic surgerypartial thickness excision

Outcome Measures

Primary Outcomes (1)

  • Hair Growth measured clinically by hair density percentage compared to baseline photo

    To evaluate hair growth following partial thickness excision of SCCIS at 3 and 6 months post-procedure.

    3 and 6 months post-procedure.

Secondary Outcomes (3)

  • Clearance of SCCIS measured by Mohs surgeons' interpretation of margins on surgical slides.

    Immediately following the final Mohs stage during the index procedure

  • Patient Satisfaction measured via patient satisfaction questionnaire

    3 and 6 months post-procedure

  • Complications

    2 weeks post-procedure, 3 months post-procedure, and 6 months post-procedure

Study Arms (1)

Partial Thickness Excision

EXPERIMENTAL

Participants will receive excision of their squamous cell carcinoma in situ of the scalp via partial thickness excision (removal of epidermal and superficial dermal tissue) in an effort to preserve hair follicles and hair growth potential.

Procedure: Partial Thickness Excision

Interventions

Participants will receive excision of their squamous cell carcinoma in situ of the scalp via partial thickness excision (removal of epidermal and superficial dermal tissue) in an effort to preserve hair follicles and hair growth potential.

Partial Thickness Excision

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults ≥ 18 years old
  • Histologically confirmed SCCIS
  • Lesions located in the hair-bearing scalp
  • Ability to provide informed consent

You may not qualify if:

  • Invasive, poorly differentiated, or high-risk SCC features (e.g., perineural invasion)
  • Recurrent SCC at the same site
  • Prior radiation therapy to the scalp
  • Scarring alopecia or active inflammatory scalp disease at the treatment site
  • Immunosuppression that, in the investigator's judgement, increases oncologic risk
  • Use of topical minoxidil, oral minoxidil, finasteride, spironolactone, or other hair-growth promoting agents

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Carcinoma, Squamous CellSquamous Intraepithelial LesionsAlopecia

Condition Hierarchy (Ancestors)

CarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsNeoplasms, Squamous CellMorphological and Microscopic FindingsPathological Conditions, Signs and SymptomsHypotrichosisHair DiseasesSkin DiseasesSkin and Connective Tissue DiseasesPathological Conditions, Anatomical

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

August 4, 2026

First Posted

September 9, 2026

Study Start

September 1, 2026

Primary Completion (Estimated)

July 17, 2027

Study Completion (Estimated)

July 17, 2028

Last Updated

September 9, 2026

Record last verified: 2026-07